nodes	percent_of_prediction	percent_of_DWPC	metapath
Amoxapine—HRH1—atherosclerosis	0.624	1	CbGaD
Amoxapine—CYP2D6—Niacin—atherosclerosis	0.0138	0.3	CbGbCtD
Amoxapine—CYP2D6—Simvastatin—atherosclerosis	0.0109	0.237	CbGbCtD
Amoxapine—CYP2D6—Lovastatin—atherosclerosis	0.0107	0.232	CbGbCtD
Amoxapine—CYP2D6—Pravastatin—atherosclerosis	0.0107	0.232	CbGbCtD
Amoxapine—HTR2A—arteriole—atherosclerosis	0.00342	0.123	CbGeAlD
Amoxapine—HTR7—vein—atherosclerosis	0.00327	0.118	CbGeAlD
Amoxapine—HTR2A—vein—atherosclerosis	0.00204	0.0734	CbGeAlD
Amoxapine—Nightmare—Rosuvastatin—atherosclerosis	0.00194	0.013	CcSEcCtD
Amoxapine—Tingling sensation—Niacin—atherosclerosis	0.00182	0.0122	CcSEcCtD
Amoxapine—Desloratadine—HRH1—atherosclerosis	0.0018	0.319	CrCbGaD
Amoxapine—Gynaecomastia—Rosuvastatin—atherosclerosis	0.0018	0.012	CcSEcCtD
Amoxapine—Vasculitis—Lovastatin—atherosclerosis	0.00175	0.0117	CcSEcCtD
Amoxapine—Numbness—Pravastatin—atherosclerosis	0.00174	0.0116	CcSEcCtD
Amoxapine—HTR1B—artery—atherosclerosis	0.00173	0.0622	CbGeAlD
Amoxapine—Vasculitis—Ezetimibe—atherosclerosis	0.00171	0.0114	CcSEcCtD
Amoxapine—Sensory loss—Pravastatin—atherosclerosis	0.00166	0.0111	CcSEcCtD
Amoxapine—Vasculitis—Simvastatin—atherosclerosis	0.00163	0.0109	CcSEcCtD
Amoxapine—Nightmare—Simvastatin—atherosclerosis	0.00154	0.0103	CcSEcCtD
Amoxapine—Gynaecomastia—Lovastatin—atherosclerosis	0.00153	0.0102	CcSEcCtD
Amoxapine—Vasculitis—Pravastatin—atherosclerosis	0.00148	0.00986	CcSEcCtD
Amoxapine—Gynaecomastia—Simvastatin—atherosclerosis	0.00143	0.00953	CcSEcCtD
Amoxapine—Nightmare—Pravastatin—atherosclerosis	0.00139	0.0093	CcSEcCtD
Amoxapine—Vascular purpura—Lovastatin—atherosclerosis	0.00138	0.00924	CcSEcCtD
Amoxapine—HTR2A—hindlimb—atherosclerosis	0.00136	0.0488	CbGeAlD
Amoxapine—HTR1B—blood vessel—atherosclerosis	0.00135	0.0484	CbGeAlD
Amoxapine—HTR7—artery—atherosclerosis	0.00133	0.0479	CbGeAlD
Amoxapine—Vascular purpura—Simvastatin—atherosclerosis	0.00129	0.00864	CcSEcCtD
Amoxapine—Gynaecomastia—Pravastatin—atherosclerosis	0.00129	0.00861	CcSEcCtD
Amoxapine—Purpura—Lovastatin—atherosclerosis	0.00128	0.00857	CcSEcCtD
Amoxapine—Pancreatitis—Rosuvastatin—atherosclerosis	0.00124	0.00826	CcSEcCtD
Amoxapine—Atrial fibrillation—Simvastatin—atherosclerosis	0.00122	0.00816	CcSEcCtD
Amoxapine—Purpura—Simvastatin—atherosclerosis	0.0012	0.00802	CcSEcCtD
Amoxapine—Vascular purpura—Pravastatin—atherosclerosis	0.00117	0.00781	CcSEcCtD
Amoxapine—HTR2A—appendage—atherosclerosis	0.00116	0.0418	CbGeAlD
Amoxapine—Asenapine—HRH1—atherosclerosis	0.00116	0.206	CrCbGaD
Amoxapine—HTR7—endothelium—atherosclerosis	0.00113	0.0405	CbGeAlD
Amoxapine—Atrial fibrillation—Niacin—atherosclerosis	0.00112	0.00749	CcSEcCtD
Amoxapine—Jaundice—Rosuvastatin—atherosclerosis	0.0011	0.00733	CcSEcCtD
Amoxapine—Purpura—Pravastatin—atherosclerosis	0.00109	0.00725	CcSEcCtD
Amoxapine—Eosinophilia—Lovastatin—atherosclerosis	0.00106	0.00707	CcSEcCtD
Amoxapine—Disturbance in sexual arousal—Niacin—atherosclerosis	0.00105	0.00704	CcSEcCtD
Amoxapine—Pancreatitis—Lovastatin—atherosclerosis	0.00105	0.007	CcSEcCtD
Amoxapine—Eosinophilia—Ezetimibe—atherosclerosis	0.00104	0.00694	CcSEcCtD
Amoxapine—HTR7—blood vessel—atherosclerosis	0.00104	0.0373	CbGeAlD
Amoxapine—Pancreatitis—Ezetimibe—atherosclerosis	0.00103	0.00687	CcSEcCtD
Amoxapine—Urinary retention—Niacin—atherosclerosis	0.00101	0.00675	CcSEcCtD
Amoxapine—Hepatitis—Rosuvastatin—atherosclerosis	0.00101	0.00675	CcSEcCtD
Amoxapine—Eosinophilia—Simvastatin—atherosclerosis	0.000991	0.00662	CcSEcCtD
Amoxapine—Erectile dysfunction—Lovastatin—atherosclerosis	0.000986	0.00658	CcSEcCtD
Amoxapine—Pancreatitis—Simvastatin—atherosclerosis	0.000981	0.00655	CcSEcCtD
Amoxapine—Erectile dysfunction—Ezetimibe—atherosclerosis	0.000967	0.00645	CcSEcCtD
Amoxapine—Erectile dysfunction—Simvastatin—atherosclerosis	0.000922	0.00615	CcSEcCtD
Amoxapine—Jaundice—Ezetimibe—atherosclerosis	0.000912	0.00609	CcSEcCtD
Amoxapine—Eosinophilia—Pravastatin—atherosclerosis	0.000896	0.00598	CcSEcCtD
Amoxapine—Pancreatitis—Pravastatin—atherosclerosis	0.000887	0.00592	CcSEcCtD
Amoxapine—Jaundice—Simvastatin—atherosclerosis	0.00087	0.00581	CcSEcCtD
Amoxapine—Flatulence—Rosuvastatin—atherosclerosis	0.000867	0.00579	CcSEcCtD
Amoxapine—Hepatitis—Lovastatin—atherosclerosis	0.000857	0.00572	CcSEcCtD
Amoxapine—Erectile dysfunction—Niacin—atherosclerosis	0.000846	0.00565	CcSEcCtD
Amoxapine—Hepatitis—Ezetimibe—atherosclerosis	0.00084	0.00561	CcSEcCtD
Amoxapine—Erectile dysfunction—Pravastatin—atherosclerosis	0.000833	0.00556	CcSEcCtD
Amoxapine—HTR2A—artery—atherosclerosis	0.000831	0.0299	CbGeAlD
Amoxapine—Weight increased—Pravastatin—atherosclerosis	0.000824	0.0055	CcSEcCtD
Amoxapine—Hepatitis—Simvastatin—atherosclerosis	0.000801	0.00535	CcSEcCtD
Amoxapine—Stomatitis—Niacin—atherosclerosis	0.000799	0.00533	CcSEcCtD
Amoxapine—Jaundice—Niacin—atherosclerosis	0.000799	0.00533	CcSEcCtD
Amoxapine—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000795	0.00531	CcSEcCtD
Amoxapine—Myocardial infarction—Pravastatin—atherosclerosis	0.000791	0.00528	CcSEcCtD
Amoxapine—Jaundice—Pravastatin—atherosclerosis	0.000786	0.00525	CcSEcCtD
Amoxapine—Alopecia—Lovastatin—atherosclerosis	0.000757	0.00505	CcSEcCtD
Amoxapine—Alopecia—Ezetimibe—atherosclerosis	0.000742	0.00496	CcSEcCtD
Amoxapine—Hepatitis—Niacin—atherosclerosis	0.000736	0.00491	CcSEcCtD
Amoxapine—Flatulence—Lovastatin—atherosclerosis	0.000735	0.0049	CcSEcCtD
Amoxapine—Hypoaesthesia—Niacin—atherosclerosis	0.000732	0.00489	CcSEcCtD
Amoxapine—Dysgeusia—Lovastatin—atherosclerosis	0.00073	0.00487	CcSEcCtD
Amoxapine—Hepatitis—Pravastatin—atherosclerosis	0.000724	0.00483	CcSEcCtD
Amoxapine—Confusional state—Rosuvastatin—atherosclerosis	0.000724	0.00483	CcSEcCtD
Amoxapine—Hypoaesthesia—Pravastatin—atherosclerosis	0.000721	0.00481	CcSEcCtD
Amoxapine—Flatulence—Ezetimibe—atherosclerosis	0.000721	0.00481	CcSEcCtD
Amoxapine—Alopecia—Simvastatin—atherosclerosis	0.000708	0.00473	CcSEcCtD
Amoxapine—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000703	0.00469	CcSEcCtD
Amoxapine—Vision blurred—Lovastatin—atherosclerosis	0.000703	0.00469	CcSEcCtD
Amoxapine—HTR2A—endothelium—atherosclerosis	0.000702	0.0253	CbGeAlD
Amoxapine—Tremor—Lovastatin—atherosclerosis	0.000699	0.00466	CcSEcCtD
Amoxapine—Flatulence—Simvastatin—atherosclerosis	0.000687	0.00459	CcSEcCtD
Amoxapine—Tinnitus—Niacin—atherosclerosis	0.000686	0.00458	CcSEcCtD
Amoxapine—Dysgeusia—Simvastatin—atherosclerosis	0.000683	0.00456	CcSEcCtD
Amoxapine—Zuclopenthixol—HRH1—atherosclerosis	0.000679	0.12	CrCbGaD
Amoxapine—Tinnitus—Pravastatin—atherosclerosis	0.000675	0.00451	CcSEcCtD
Amoxapine—Leukopenia—Lovastatin—atherosclerosis	0.000667	0.00446	CcSEcCtD
Amoxapine—Vision blurred—Simvastatin—atherosclerosis	0.000657	0.00439	CcSEcCtD
Amoxapine—Tremor—Simvastatin—atherosclerosis	0.000653	0.00436	CcSEcCtD
Amoxapine—Alopecia—Niacin—atherosclerosis	0.00065	0.00434	CcSEcCtD
Amoxapine—Insomnia—Rosuvastatin—atherosclerosis	0.000649	0.00434	CcSEcCtD
Amoxapine—HTR2A—blood vessel—atherosclerosis	0.000647	0.0233	CbGeAlD
Amoxapine—Palpitations—Ezetimibe—atherosclerosis	0.000646	0.00431	CcSEcCtD
Amoxapine—Olanzapine—HRH1—atherosclerosis	0.000646	0.114	CrCbGaD
Amoxapine—Paraesthesia—Rosuvastatin—atherosclerosis	0.000645	0.0043	CcSEcCtD
Amoxapine—Alopecia—Pravastatin—atherosclerosis	0.00064	0.00427	CcSEcCtD
Amoxapine—Dyspepsia—Rosuvastatin—atherosclerosis	0.000632	0.00422	CcSEcCtD
Amoxapine—Hypertension—Ezetimibe—atherosclerosis	0.000631	0.00421	CcSEcCtD
Amoxapine—Flatulence—Niacin—atherosclerosis	0.000631	0.00421	CcSEcCtD
Amoxapine—Tension—Niacin—atherosclerosis	0.000628	0.00419	CcSEcCtD
Amoxapine—Leukopenia—Simvastatin—atherosclerosis	0.000624	0.00417	CcSEcCtD
Amoxapine—Nervousness—Niacin—atherosclerosis	0.000622	0.00415	CcSEcCtD
Amoxapine—Flatulence—Pravastatin—atherosclerosis	0.000621	0.00415	CcSEcCtD
Amoxapine—Dry mouth—Lovastatin—atherosclerosis	0.000621	0.00414	CcSEcCtD
Amoxapine—Tension—Pravastatin—atherosclerosis	0.000619	0.00413	CcSEcCtD
Amoxapine—Dysgeusia—Pravastatin—atherosclerosis	0.000617	0.00412	CcSEcCtD
Amoxapine—Constipation—Rosuvastatin—atherosclerosis	0.000614	0.0041	CcSEcCtD
Amoxapine—Confusional state—Lovastatin—atherosclerosis	0.000614	0.0041	CcSEcCtD
Amoxapine—Nervousness—Pravastatin—atherosclerosis	0.000612	0.00409	CcSEcCtD
Amoxapine—Dry mouth—Ezetimibe—atherosclerosis	0.000609	0.00406	CcSEcCtD
Amoxapine—Vision blurred—Niacin—atherosclerosis	0.000604	0.00403	CcSEcCtD
Amoxapine—Confusional state—Ezetimibe—atherosclerosis	0.000602	0.00402	CcSEcCtD
Amoxapine—HTR1B—cardiovascular system—atherosclerosis	0.0006	0.0216	CbGeAlD
Amoxapine—Thrombocytopenia—Lovastatin—atherosclerosis	0.000596	0.00398	CcSEcCtD
Amoxapine—Vision blurred—Pravastatin—atherosclerosis	0.000594	0.00397	CcSEcCtD
Amoxapine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000592	0.00395	CcSEcCtD
Amoxapine—Tremor—Pravastatin—atherosclerosis	0.000591	0.00394	CcSEcCtD
Amoxapine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000587	0.00392	CcSEcCtD
Amoxapine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000584	0.0039	CcSEcCtD
Amoxapine—Anorexia—Lovastatin—atherosclerosis	0.00058	0.00387	CcSEcCtD
Amoxapine—Syncope—Niacin—atherosclerosis	0.000574	0.00383	CcSEcCtD
Amoxapine—Confusional state—Simvastatin—atherosclerosis	0.000574	0.00383	CcSEcCtD
Amoxapine—Leukopenia—Niacin—atherosclerosis	0.000573	0.00383	CcSEcCtD
Amoxapine—Urticaria—Rosuvastatin—atherosclerosis	0.00057	0.00381	CcSEcCtD
Amoxapine—Oedema—Simvastatin—atherosclerosis	0.000569	0.0038	CcSEcCtD
Amoxapine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000568	0.00379	CcSEcCtD
Amoxapine—Palpitations—Niacin—atherosclerosis	0.000566	0.00378	CcSEcCtD
Amoxapine—Leukopenia—Pravastatin—atherosclerosis	0.000564	0.00377	CcSEcCtD
Amoxapine—Loss of consciousness—Niacin—atherosclerosis	0.000563	0.00376	CcSEcCtD
Amoxapine—Thrombocytopenia—Simvastatin—atherosclerosis	0.000557	0.00372	CcSEcCtD
Amoxapine—Insomnia—Lovastatin—atherosclerosis	0.00055	0.00367	CcSEcCtD
Amoxapine—Paraesthesia—Lovastatin—atherosclerosis	0.000546	0.00365	CcSEcCtD
Amoxapine—Hypertension—Pravastatin—atherosclerosis	0.000544	0.00363	CcSEcCtD
Amoxapine—CHRM1—cardiovascular system—atherosclerosis	0.000544	0.0196	CbGeAlD
Amoxapine—Anorexia—Simvastatin—atherosclerosis	0.000543	0.00362	CcSEcCtD
Amoxapine—HTR2B—cardiovascular system—atherosclerosis	0.000541	0.0195	CbGeAlD
Amoxapine—Insomnia—Ezetimibe—atherosclerosis	0.00054	0.0036	CcSEcCtD
Amoxapine—Paraesthesia—Ezetimibe—atherosclerosis	0.000536	0.00358	CcSEcCtD
Amoxapine—Dyspepsia—Lovastatin—atherosclerosis	0.000536	0.00358	CcSEcCtD
Amoxapine—Dry mouth—Niacin—atherosclerosis	0.000533	0.00356	CcSEcCtD
Amoxapine—HTR7—connective tissue—atherosclerosis	0.000532	0.0191	CbGeAlD
Amoxapine—Decreased appetite—Lovastatin—atherosclerosis	0.000529	0.00353	CcSEcCtD
Amoxapine—Dyspepsia—Ezetimibe—atherosclerosis	0.000525	0.00351	CcSEcCtD
Amoxapine—Fatigue—Lovastatin—atherosclerosis	0.000525	0.0035	CcSEcCtD
Amoxapine—Oedema—Niacin—atherosclerosis	0.000523	0.00349	CcSEcCtD
Amoxapine—Constipation—Lovastatin—atherosclerosis	0.00052	0.00347	CcSEcCtD
Amoxapine—Confusional state—Pravastatin—atherosclerosis	0.000519	0.00346	CcSEcCtD
Amoxapine—Decreased appetite—Ezetimibe—atherosclerosis	0.000519	0.00346	CcSEcCtD
Amoxapine—Asthenia—Rosuvastatin—atherosclerosis	0.000515	0.00344	CcSEcCtD
Amoxapine—Insomnia—Simvastatin—atherosclerosis	0.000515	0.00344	CcSEcCtD
Amoxapine—Oedema—Pravastatin—atherosclerosis	0.000515	0.00343	CcSEcCtD
Amoxapine—Fatigue—Ezetimibe—atherosclerosis	0.000515	0.00343	CcSEcCtD
Amoxapine—Shock—Niacin—atherosclerosis	0.000514	0.00343	CcSEcCtD
Amoxapine—Paraesthesia—Simvastatin—atherosclerosis	0.000511	0.00341	CcSEcCtD
Amoxapine—Constipation—Ezetimibe—atherosclerosis	0.00051	0.00341	CcSEcCtD
Amoxapine—Tachycardia—Niacin—atherosclerosis	0.00051	0.0034	CcSEcCtD
Amoxapine—Pruritus—Rosuvastatin—atherosclerosis	0.000508	0.00339	CcSEcCtD
Amoxapine—Thrombocytopenia—Pravastatin—atherosclerosis	0.000504	0.00336	CcSEcCtD
Amoxapine—Feeling abnormal—Lovastatin—atherosclerosis	0.000501	0.00335	CcSEcCtD
Amoxapine—Dyspepsia—Simvastatin—atherosclerosis	0.000501	0.00334	CcSEcCtD
Amoxapine—Anorexia—Niacin—atherosclerosis	0.000498	0.00333	CcSEcCtD
Amoxapine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000498	0.00332	CcSEcCtD
Amoxapine—Decreased appetite—Simvastatin—atherosclerosis	0.000495	0.0033	CcSEcCtD
Amoxapine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000492	0.00328	CcSEcCtD
Amoxapine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000491	0.00328	CcSEcCtD
Amoxapine—Fatigue—Simvastatin—atherosclerosis	0.000491	0.00328	CcSEcCtD
Amoxapine—Anorexia—Pravastatin—atherosclerosis	0.000491	0.00327	CcSEcCtD
Amoxapine—Hypotension—Niacin—atherosclerosis	0.000488	0.00326	CcSEcCtD
Amoxapine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000488	0.00326	CcSEcCtD
Amoxapine—Constipation—Simvastatin—atherosclerosis	0.000487	0.00325	CcSEcCtD
Amoxapine—HTR1A—cardiovascular system—atherosclerosis	0.000485	0.0174	CbGeAlD
Amoxapine—Urticaria—Lovastatin—atherosclerosis	0.000483	0.00323	CcSEcCtD
Amoxapine—Abdominal pain—Lovastatin—atherosclerosis	0.000481	0.00321	CcSEcCtD
Amoxapine—Body temperature increased—Lovastatin—atherosclerosis	0.000481	0.00321	CcSEcCtD
Amoxapine—HTR2B—adipose tissue—atherosclerosis	0.000477	0.0172	CbGeAlD
Amoxapine—Dizziness—Rosuvastatin—atherosclerosis	0.000475	0.00317	CcSEcCtD
Amoxapine—Urticaria—Ezetimibe—atherosclerosis	0.000474	0.00316	CcSEcCtD
Amoxapine—Insomnia—Niacin—atherosclerosis	0.000473	0.00316	CcSEcCtD
Amoxapine—Abdominal pain—Ezetimibe—atherosclerosis	0.000472	0.00315	CcSEcCtD
Amoxapine—Body temperature increased—Ezetimibe—atherosclerosis	0.000472	0.00315	CcSEcCtD
Amoxapine—Paraesthesia—Niacin—atherosclerosis	0.000469	0.00313	CcSEcCtD
Amoxapine—Feeling abnormal—Simvastatin—atherosclerosis	0.000469	0.00313	CcSEcCtD
Amoxapine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000465	0.00311	CcSEcCtD
Amoxapine—Insomnia—Pravastatin—atherosclerosis	0.000465	0.00311	CcSEcCtD
Amoxapine—Somnolence—Niacin—atherosclerosis	0.000465	0.0031	CcSEcCtD
Amoxapine—HTR7—cardiovascular system—atherosclerosis	0.000463	0.0167	CbGeAlD
Amoxapine—Paraesthesia—Pravastatin—atherosclerosis	0.000462	0.00308	CcSEcCtD
Amoxapine—Dyspepsia—Niacin—atherosclerosis	0.00046	0.00307	CcSEcCtD
Amoxapine—Decreased appetite—Niacin—atherosclerosis	0.000454	0.00303	CcSEcCtD
Amoxapine—Dyspepsia—Pravastatin—atherosclerosis	0.000453	0.00302	CcSEcCtD
Amoxapine—Rash—Rosuvastatin—atherosclerosis	0.000453	0.00302	CcSEcCtD
Amoxapine—Dermatitis—Rosuvastatin—atherosclerosis	0.000452	0.00302	CcSEcCtD
Amoxapine—Urticaria—Simvastatin—atherosclerosis	0.000452	0.00302	CcSEcCtD
Amoxapine—Abdominal pain—Simvastatin—atherosclerosis	0.00045	0.003	CcSEcCtD
Amoxapine—Body temperature increased—Simvastatin—atherosclerosis	0.00045	0.003	CcSEcCtD
Amoxapine—Headache—Rosuvastatin—atherosclerosis	0.00045	0.003	CcSEcCtD
Amoxapine—Decreased appetite—Pravastatin—atherosclerosis	0.000447	0.00299	CcSEcCtD
Amoxapine—ADRA1A—cardiovascular system—atherosclerosis	0.000447	0.0161	CbGeAlD
Amoxapine—Fatigue—Pravastatin—atherosclerosis	0.000444	0.00296	CcSEcCtD
Amoxapine—Constipation—Pravastatin—atherosclerosis	0.00044	0.00294	CcSEcCtD
Amoxapine—Asthenia—Lovastatin—atherosclerosis	0.000437	0.00291	CcSEcCtD
Amoxapine—Pruritus—Lovastatin—atherosclerosis	0.000431	0.00287	CcSEcCtD
Amoxapine—Asthenia—Ezetimibe—atherosclerosis	0.000428	0.00286	CcSEcCtD
Amoxapine—Gastrointestinal pain—Niacin—atherosclerosis	0.000427	0.00285	CcSEcCtD
Amoxapine—Nausea—Rosuvastatin—atherosclerosis	0.000427	0.00285	CcSEcCtD
Amoxapine—Feeling abnormal—Pravastatin—atherosclerosis	0.000424	0.00283	CcSEcCtD
Amoxapine—Pruritus—Ezetimibe—atherosclerosis	0.000422	0.00282	CcSEcCtD
Amoxapine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000421	0.00281	CcSEcCtD
Amoxapine—Diarrhoea—Lovastatin—atherosclerosis	0.000416	0.00278	CcSEcCtD
Amoxapine—Urticaria—Niacin—atherosclerosis	0.000415	0.00277	CcSEcCtD
Amoxapine—Body temperature increased—Niacin—atherosclerosis	0.000413	0.00276	CcSEcCtD
Amoxapine—Abdominal pain—Niacin—atherosclerosis	0.000413	0.00276	CcSEcCtD
Amoxapine—Urticaria—Pravastatin—atherosclerosis	0.000409	0.00273	CcSEcCtD
Amoxapine—Asthenia—Simvastatin—atherosclerosis	0.000408	0.00273	CcSEcCtD
Amoxapine—Diarrhoea—Ezetimibe—atherosclerosis	0.000408	0.00273	CcSEcCtD
Amoxapine—Body temperature increased—Pravastatin—atherosclerosis	0.000407	0.00272	CcSEcCtD
Amoxapine—Abdominal pain—Pravastatin—atherosclerosis	0.000407	0.00272	CcSEcCtD
Amoxapine—Pruritus—Simvastatin—atherosclerosis	0.000403	0.00269	CcSEcCtD
Amoxapine—Dizziness—Lovastatin—atherosclerosis	0.000402	0.00269	CcSEcCtD
Amoxapine—Loxapine—HRH1—atherosclerosis	0.000402	0.0711	CrCbGaD
Amoxapine—HRH1—connective tissue—atherosclerosis	0.000397	0.0143	CbGeAlD
Amoxapine—ORM1—liver—atherosclerosis	0.000396	0.0142	CbGeAlD
Amoxapine—Dizziness—Ezetimibe—atherosclerosis	0.000395	0.00263	CcSEcCtD
Amoxapine—ADRA1A—adipose tissue—atherosclerosis	0.000394	0.0142	CbGeAlD
Amoxapine—Quetiapine—HRH1—atherosclerosis	0.000392	0.0694	CrCbGaD
Amoxapine—ADRA2A—connective tissue—atherosclerosis	0.00039	0.014	CbGeAlD
Amoxapine—Diarrhoea—Simvastatin—atherosclerosis	0.000389	0.0026	CcSEcCtD
Amoxapine—Vomiting—Lovastatin—atherosclerosis	0.000387	0.00258	CcSEcCtD
Amoxapine—Rash—Lovastatin—atherosclerosis	0.000384	0.00256	CcSEcCtD
Amoxapine—Dermatitis—Lovastatin—atherosclerosis	0.000383	0.00256	CcSEcCtD
Amoxapine—Headache—Lovastatin—atherosclerosis	0.000381	0.00254	CcSEcCtD
Amoxapine—Vomiting—Ezetimibe—atherosclerosis	0.000379	0.00253	CcSEcCtD
Amoxapine—Dizziness—Simvastatin—atherosclerosis	0.000376	0.00251	CcSEcCtD
Amoxapine—Rash—Ezetimibe—atherosclerosis	0.000376	0.00251	CcSEcCtD
Amoxapine—Dermatitis—Ezetimibe—atherosclerosis	0.000376	0.00251	CcSEcCtD
Amoxapine—Asthenia—Niacin—atherosclerosis	0.000375	0.0025	CcSEcCtD
Amoxapine—Headache—Ezetimibe—atherosclerosis	0.000374	0.0025	CcSEcCtD
Amoxapine—Pruritus—Niacin—atherosclerosis	0.00037	0.00247	CcSEcCtD
Amoxapine—Asthenia—Pravastatin—atherosclerosis	0.000369	0.00246	CcSEcCtD
Amoxapine—Pruritus—Pravastatin—atherosclerosis	0.000364	0.00243	CcSEcCtD
Amoxapine—Vomiting—Simvastatin—atherosclerosis	0.000362	0.00242	CcSEcCtD
Amoxapine—Nausea—Lovastatin—atherosclerosis	0.000361	0.00241	CcSEcCtD
Amoxapine—Rash—Simvastatin—atherosclerosis	0.000359	0.0024	CcSEcCtD
Amoxapine—Dermatitis—Simvastatin—atherosclerosis	0.000359	0.00239	CcSEcCtD
Amoxapine—Diarrhoea—Niacin—atherosclerosis	0.000358	0.00239	CcSEcCtD
Amoxapine—Headache—Simvastatin—atherosclerosis	0.000357	0.00238	CcSEcCtD
Amoxapine—Nausea—Ezetimibe—atherosclerosis	0.000355	0.00237	CcSEcCtD
Amoxapine—Diarrhoea—Pravastatin—atherosclerosis	0.000352	0.00235	CcSEcCtD
Amoxapine—Dizziness—Niacin—atherosclerosis	0.000346	0.00231	CcSEcCtD
Amoxapine—Dizziness—Pravastatin—atherosclerosis	0.00034	0.00227	CcSEcCtD
Amoxapine—Nausea—Simvastatin—atherosclerosis	0.000338	0.00226	CcSEcCtD
Amoxapine—Clozapine—HRH1—atherosclerosis	0.000337	0.0597	CrCbGaD
Amoxapine—Vomiting—Niacin—atherosclerosis	0.000332	0.00222	CcSEcCtD
Amoxapine—HTR2A—connective tissue—atherosclerosis	0.000332	0.0119	CbGeAlD
Amoxapine—Rash—Niacin—atherosclerosis	0.00033	0.0022	CcSEcCtD
Amoxapine—Dermatitis—Niacin—atherosclerosis	0.000329	0.0022	CcSEcCtD
Amoxapine—Headache—Niacin—atherosclerosis	0.000327	0.00219	CcSEcCtD
Amoxapine—Vomiting—Pravastatin—atherosclerosis	0.000327	0.00218	CcSEcCtD
Amoxapine—Rash—Pravastatin—atherosclerosis	0.000324	0.00217	CcSEcCtD
Amoxapine—Dermatitis—Pravastatin—atherosclerosis	0.000324	0.00216	CcSEcCtD
Amoxapine—Headache—Pravastatin—atherosclerosis	0.000322	0.00215	CcSEcCtD
Amoxapine—Nausea—Niacin—atherosclerosis	0.00031	0.00207	CcSEcCtD
Amoxapine—Nausea—Pravastatin—atherosclerosis	0.000306	0.00204	CcSEcCtD
Amoxapine—HRH1—adipose tissue—atherosclerosis	0.000305	0.011	CbGeAlD
Amoxapine—ADRA2A—adipose tissue—atherosclerosis	0.0003	0.0108	CbGeAlD
Amoxapine—HTR2A—cardiovascular system—atherosclerosis	0.000289	0.0104	CbGeAlD
Amoxapine—HTR7—liver—atherosclerosis	0.000286	0.0103	CbGeAlD
Amoxapine—ADRA1A—liver—atherosclerosis	0.000276	0.00994	CbGeAlD
Amoxapine—HTR2A—liver—atherosclerosis	0.000179	0.00642	CbGeAlD
Amoxapine—CYP2D6—liver—atherosclerosis	0.000163	0.00585	CbGeAlD
Amoxapine—Olanzapine—ALB—atherosclerosis	0.000149	0.0264	CrCbGaD
Amoxapine—Diazepam—ALB—atherosclerosis	7.89e-05	0.014	CrCbGaD
Amoxapine—HTR1B—Signaling Pathways—MMP9—atherosclerosis	5.71e-06	3.9e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—MAPK8—atherosclerosis	5.71e-06	3.9e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—AKT1—atherosclerosis	5.7e-06	3.9e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—AKT1—atherosclerosis	5.7e-06	3.89e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—APOE—atherosclerosis	5.69e-06	3.89e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—LEP—atherosclerosis	5.69e-06	3.89e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—SERPINE1—atherosclerosis	5.68e-06	3.88e-05	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—AKT1—atherosclerosis	5.67e-06	3.87e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—SERPINE1—atherosclerosis	5.65e-06	3.86e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—NFKB1—atherosclerosis	5.65e-06	3.86e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—PIK3CG—atherosclerosis	5.65e-06	3.86e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—IL6—atherosclerosis	5.64e-06	3.86e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CAV1—atherosclerosis	5.64e-06	3.85e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—PIK3CG—atherosclerosis	5.63e-06	3.85e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—APOA1—atherosclerosis	5.63e-06	3.84e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—MMP9—atherosclerosis	5.62e-06	3.84e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—PIK3CG—atherosclerosis	5.62e-06	3.84e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CXCL8—atherosclerosis	5.6e-06	3.82e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—NFKB1—atherosclerosis	5.56e-06	3.8e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—MAPK8—atherosclerosis	5.56e-06	3.8e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—AKT1—atherosclerosis	5.54e-06	3.79e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—APOB—atherosclerosis	5.54e-06	3.79e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—PIK3CG—atherosclerosis	5.53e-06	3.78e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CXCL8—atherosclerosis	5.52e-06	3.77e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—MAPK3—atherosclerosis	5.5e-06	3.75e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—MAPK8—atherosclerosis	5.47e-06	3.74e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—AKT1—atherosclerosis	5.45e-06	3.73e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—ESR1—atherosclerosis	5.43e-06	3.71e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—INS—atherosclerosis	5.43e-06	3.71e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—NOS3—atherosclerosis	5.43e-06	3.71e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—MAPK3—atherosclerosis	5.41e-06	3.69e-05	CbGpPWpGaD
Amoxapine—DRD1—GPCR downstream signaling—AKT1—atherosclerosis	5.41e-06	3.69e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—NOS3—atherosclerosis	5.4e-06	3.69e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—MAPK3—atherosclerosis	5.4e-06	3.69e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—GSTM1—atherosclerosis	5.39e-06	3.68e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—MAPK3—atherosclerosis	5.38e-06	3.67e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—MMP9—atherosclerosis	5.37e-06	3.67e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—F2—atherosclerosis	5.37e-06	3.67e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—INS—atherosclerosis	5.35e-06	3.65e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CCL2—atherosclerosis	5.35e-06	3.65e-05	CbGpPWpGaD
Amoxapine—DRD3—GPCR downstream signaling—AKT1—atherosclerosis	5.34e-06	3.64e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—INS—atherosclerosis	5.33e-06	3.64e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—ALB—atherosclerosis	5.33e-06	3.64e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—IL6—atherosclerosis	5.32e-06	3.64e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—INS—atherosclerosis	5.32e-06	3.63e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—NFKB1—atherosclerosis	5.31e-06	3.63e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—MAPK3—atherosclerosis	5.3e-06	3.62e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—LPL—atherosclerosis	5.29e-06	3.62e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—VEGFA—atherosclerosis	5.28e-06	3.61e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—VEGFA—atherosclerosis	5.28e-06	3.6e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CCL2—atherosclerosis	5.26e-06	3.59e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IGF1—atherosclerosis	5.25e-06	3.59e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—IL6—atherosclerosis	5.25e-06	3.59e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CCL2—atherosclerosis	5.25e-06	3.58e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—INS—atherosclerosis	5.23e-06	3.58e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CCL2—atherosclerosis	5.23e-06	3.57e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—STAT3—atherosclerosis	5.23e-06	3.57e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—STAT3—atherosclerosis	5.22e-06	3.57e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—MAPK8—atherosclerosis	5.22e-06	3.57e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—AKT1—atherosclerosis	5.21e-06	3.56e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IGF1—atherosclerosis	5.17e-06	3.53e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—GPX1—atherosclerosis	5.16e-06	3.53e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IGF1—atherosclerosis	5.16e-06	3.52e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CCL2—atherosclerosis	5.15e-06	3.52e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IGF1—atherosclerosis	5.14e-06	3.51e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—PIK3CG—atherosclerosis	5.14e-06	3.51e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—VEGFA—atherosclerosis	5.13e-06	3.51e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—NOS3—atherosclerosis	5.1e-06	3.48e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—STAT3—atherosclerosis	5.08e-06	3.47e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IGF1—atherosclerosis	5.06e-06	3.46e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—MMP9—atherosclerosis	5.06e-06	3.46e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—VEGFA—atherosclerosis	5.05e-06	3.45e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—CD36—atherosclerosis	5.03e-06	3.44e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—NFKB1—atherosclerosis	5.01e-06	3.42e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—STAT3—atherosclerosis	5e-06	3.42e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—MAPK3—atherosclerosis	5e-06	3.41e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—MMP9—atherosclerosis	5e-06	3.41e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—MAPK3—atherosclerosis	4.99e-06	3.41e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—SERPINE1—atherosclerosis	4.99e-06	3.41e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—NFKB1—atherosclerosis	4.94e-06	3.38e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—MAPK8—atherosclerosis	4.92e-06	3.36e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—MAPK3—atherosclerosis	4.92e-06	3.36e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—AKT1—atherosclerosis	4.91e-06	3.35e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—SERPINE1—atherosclerosis	4.91e-06	3.35e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—SERPINE1—atherosclerosis	4.9e-06	3.35e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—SERPINE1—atherosclerosis	4.88e-06	3.34e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—INS—atherosclerosis	4.86e-06	3.32e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—MAPK8—atherosclerosis	4.86e-06	3.32e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—MAPK3—atherosclerosis	4.85e-06	3.32e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—TGFB1—atherosclerosis	4.85e-06	3.31e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—AKT1—atherosclerosis	4.84e-06	3.31e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—TGFB1—atherosclerosis	4.84e-06	3.31e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—VEGFA—atherosclerosis	4.82e-06	3.29e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CXCL8—atherosclerosis	4.81e-06	3.29e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—SERPINE1—atherosclerosis	4.81e-06	3.28e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CXCL8—atherosclerosis	4.79e-06	3.27e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CCL2—atherosclerosis	4.78e-06	3.27e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—MAPK3—atherosclerosis	4.78e-06	3.26e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—STAT3—atherosclerosis	4.77e-06	3.26e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—MTHFR—atherosclerosis	4.77e-06	3.26e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—NOS3—atherosclerosis	4.76e-06	3.25e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—TGFB1—atherosclerosis	4.71e-06	3.22e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IGF1—atherosclerosis	4.7e-06	3.21e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—NOS3—atherosclerosis	4.69e-06	3.2e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—NOS3—atherosclerosis	4.68e-06	3.2e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PPARA—atherosclerosis	4.67e-06	3.19e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—PTGS2—atherosclerosis	4.66e-06	3.19e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—NOS3—atherosclerosis	4.66e-06	3.19e-05	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—AKT1—atherosclerosis	4.65e-06	3.18e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—TGFB1—atherosclerosis	4.63e-06	3.17e-05	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—AKT1—atherosclerosis	4.63e-06	3.16e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—NOS3—atherosclerosis	4.59e-06	3.14e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—IL6—atherosclerosis	4.58e-06	3.13e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—MAPK3—atherosclerosis	4.56e-06	3.12e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—IL6—atherosclerosis	4.55e-06	3.11e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—VEGFA—atherosclerosis	4.55e-06	3.11e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—AGT—atherosclerosis	4.53e-06	3.09e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—STAT3—atherosclerosis	4.5e-06	3.07e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—VEGFA—atherosclerosis	4.49e-06	3.06e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—SERPINE1—atherosclerosis	4.47e-06	3.05e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—STAT3—atherosclerosis	4.44e-06	3.03e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—APOE—atherosclerosis	4.44e-06	3.03e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—TGFB1—atherosclerosis	4.42e-06	3.02e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—CAV1—atherosclerosis	4.4e-06	3e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—APOA1—atherosclerosis	4.39e-06	3e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—MMP9—atherosclerosis	4.35e-06	2.97e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—MMP9—atherosclerosis	4.33e-06	2.96e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—NFKB1—atherosclerosis	4.31e-06	2.94e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—MAPK3—atherosclerosis	4.3e-06	2.94e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—NFKB1—atherosclerosis	4.29e-06	2.93e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—NOS3—atherosclerosis	4.26e-06	2.91e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—MAPK3—atherosclerosis	4.24e-06	2.9e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—MAPK8—atherosclerosis	4.23e-06	2.89e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CXCL8—atherosclerosis	4.23e-06	2.89e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—AKT1—atherosclerosis	4.22e-06	2.88e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—MAPK8—atherosclerosis	4.21e-06	2.88e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—AKT1—atherosclerosis	4.2e-06	2.87e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—TGFB1—atherosclerosis	4.17e-06	2.85e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CXCL8—atherosclerosis	4.16e-06	2.84e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CXCL8—atherosclerosis	4.15e-06	2.83e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CXCL8—atherosclerosis	4.14e-06	2.83e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—TGFB1—atherosclerosis	4.12e-06	2.81e-05	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—AKT1—atherosclerosis	4.08e-06	2.79e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CXCL8—atherosclerosis	4.07e-06	2.78e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—IL6—atherosclerosis	4.02e-06	2.75e-05	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—AKT1—atherosclerosis	4.02e-06	2.74e-05	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—AKT1—atherosclerosis	4.01e-06	2.74e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PIK3CG—atherosclerosis	4e-06	2.73e-05	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—AKT1—atherosclerosis	4e-06	2.73e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—IL6—atherosclerosis	3.95e-06	2.7e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—IL6—atherosclerosis	3.95e-06	2.7e-05	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—AKT1—atherosclerosis	3.93e-06	2.69e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—IL6—atherosclerosis	3.93e-06	2.69e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—VEGFA—atherosclerosis	3.91e-06	2.67e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—VEGFA—atherosclerosis	3.89e-06	2.66e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—IL6—atherosclerosis	3.87e-06	2.64e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—STAT3—atherosclerosis	3.87e-06	2.64e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PPARG—atherosclerosis	3.86e-06	2.64e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—STAT3—atherosclerosis	3.85e-06	2.63e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MMP9—atherosclerosis	3.82e-06	2.61e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—INS—atherosclerosis	3.79e-06	2.59e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CXCL8—atherosclerosis	3.78e-06	2.58e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—NFKB1—atherosclerosis	3.78e-06	2.58e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MMP9—atherosclerosis	3.76e-06	2.57e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MMP9—atherosclerosis	3.75e-06	2.56e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MMP9—atherosclerosis	3.74e-06	2.56e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—NFKB1—atherosclerosis	3.72e-06	2.54e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MAPK8—atherosclerosis	3.72e-06	2.54e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—NFKB1—atherosclerosis	3.71e-06	2.54e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—AKT1—atherosclerosis	3.71e-06	2.53e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—NFKB1—atherosclerosis	3.7e-06	2.53e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—MAPK3—atherosclerosis	3.7e-06	2.53e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MMP9—atherosclerosis	3.68e-06	2.52e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—MAPK3—atherosclerosis	3.68e-06	2.51e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MAPK8—atherosclerosis	3.66e-06	2.5e-05	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—AKT1—atherosclerosis	3.65e-06	2.5e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—IL6—atherosclerosis	3.65e-06	2.5e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MAPK8—atherosclerosis	3.65e-06	2.49e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—IL6—atherosclerosis	3.65e-06	2.49e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—AKT1—atherosclerosis	3.65e-06	2.49e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—NFKB1—atherosclerosis	3.64e-06	2.49e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—AKT1—atherosclerosis	3.64e-06	2.49e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MAPK8—atherosclerosis	3.64e-06	2.49e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—AKT1—atherosclerosis	3.63e-06	2.48e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—IL6—atherosclerosis	3.6e-06	2.46e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—TGFB1—atherosclerosis	3.59e-06	2.45e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MAPK8—atherosclerosis	3.58e-06	2.45e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—AKT1—atherosclerosis	3.57e-06	2.44e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—TGFB1—atherosclerosis	3.57e-06	2.44e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—IL6—atherosclerosis	3.55e-06	2.42e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—IL6—atherosclerosis	3.49e-06	2.39e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—ALB—atherosclerosis	3.47e-06	2.37e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—VEGFA—atherosclerosis	3.43e-06	2.34e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MMP9—atherosclerosis	3.42e-06	2.34e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—STAT3—atherosclerosis	3.4e-06	2.32e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—NFKB1—atherosclerosis	3.39e-06	2.31e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—VEGFA—atherosclerosis	3.38e-06	2.31e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—VEGFA—atherosclerosis	3.37e-06	2.3e-05	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—AKT1—atherosclerosis	3.37e-06	2.3e-05	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—AKT1—atherosclerosis	3.37e-06	2.3e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—VEGFA—atherosclerosis	3.36e-06	2.29e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—STAT3—atherosclerosis	3.34e-06	2.28e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—STAT3—atherosclerosis	3.34e-06	2.28e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—IL6—atherosclerosis	3.33e-06	2.28e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MAPK8—atherosclerosis	3.33e-06	2.27e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—STAT3—atherosclerosis	3.33e-06	2.27e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—NOS3—atherosclerosis	3.32e-06	2.27e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—AKT1—atherosclerosis	3.32e-06	2.27e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—VEGFA—atherosclerosis	3.31e-06	2.26e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—STAT3—atherosclerosis	3.27e-06	2.24e-05	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—AKT1—atherosclerosis	3.27e-06	2.24e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MAPK3—atherosclerosis	3.25e-06	2.22e-05	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—AKT1—atherosclerosis	3.22e-06	2.2e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MAPK3—atherosclerosis	3.19e-06	2.18e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MAPK3—atherosclerosis	3.19e-06	2.18e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MAPK3—atherosclerosis	3.18e-06	2.17e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TGFB1—atherosclerosis	3.15e-06	2.15e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—IL6—atherosclerosis	3.14e-06	2.15e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MAPK3—atherosclerosis	3.13e-06	2.14e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—IL6—atherosclerosis	3.1e-06	2.12e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TGFB1—atherosclerosis	3.1e-06	2.12e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TGFB1—atherosclerosis	3.09e-06	2.11e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TGFB1—atherosclerosis	3.08e-06	2.11e-05	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—AKT1—atherosclerosis	3.08e-06	2.1e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—VEGFA—atherosclerosis	3.07e-06	2.1e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—STAT3—atherosclerosis	3.04e-06	2.08e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PTGS2—atherosclerosis	3.04e-06	2.08e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TGFB1—atherosclerosis	3.04e-06	2.07e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MAPK3—atherosclerosis	2.91e-06	1.99e-05	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—AKT1—atherosclerosis	2.9e-06	1.98e-05	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—AKT1—atherosclerosis	2.86e-06	1.96e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TGFB1—atherosclerosis	2.82e-06	1.93e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IL6—atherosclerosis	2.7e-06	1.85e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IL6—atherosclerosis	2.69e-06	1.84e-05	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—AKT1—atherosclerosis	2.49e-06	1.7e-05	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—AKT1—atherosclerosis	2.48e-06	1.7e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IL6—atherosclerosis	2.37e-06	1.62e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—AKT1—atherosclerosis	2.34e-06	1.6e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IL6—atherosclerosis	2.34e-06	1.6e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IL6—atherosclerosis	2.33e-06	1.59e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IL6—atherosclerosis	2.32e-06	1.59e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IL6—atherosclerosis	2.29e-06	1.56e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—AKT1—atherosclerosis	2.19e-06	1.5e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—AKT1—atherosclerosis	2.15e-06	1.47e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—AKT1—atherosclerosis	2.15e-06	1.47e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—AKT1—atherosclerosis	2.14e-06	1.46e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IL6—atherosclerosis	2.13e-06	1.45e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—AKT1—atherosclerosis	2.11e-06	1.44e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—AKT1—atherosclerosis	1.96e-06	1.34e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—AKT1—atherosclerosis	1.53e-06	1.04e-05	CbGpPWpGaD
